Ossiform

We’re excited to announce that Ossiform has partnered with Imbros as our new distributor for Australia and New Zealand🌏

With over 50 years of experience supplying scientific instruments across Oceania, Imbros has a strong track record of delivering innovative technologies to market, making them an ideal partner to support the distribution of Ossiform’s P3D Scaffolds in the region.

Through this collaboration, we aim to empower more researchers to explore new possibilities in bone research and tissue engineering🦴

We look forward to working with the Imbros team to support the scientific community across Australia and New Zealand.

🔗 Learn more about Imbros: https://imbros.com.au/product/ossiform-p3d-scaffolds/

Ossiform is pleased to announce that Gijs Klarenbeek, MD, has joined the company as Clinical- / Medical Affairs Advisor.

In this role, Gijs will support the continued strengthening of Ossiform’s clinical and medical affairs activities as the company prepares for launch and clinical adoption in the United States and initiates the studies to obtain the CE mark.

Gijs will contribute to the successful clinical implementation of Ossiform’s bio-integrative, 3D printed bone substitutes and surgical instrumentation across the U.S. and Europe. His work will focus on ensuring robust evidence generation and dissemination, supporting surgeon training and medical education, collaborating closely with key opinion leaders, CROs, and contributing to post-market regulatory and adoption activities.